StockData

China SXT Pharmaceuticals, Inc. (SXTC) shareholders

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.86−0.13 (-4.35%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

Ownership

Institutional holdings as of Mar 31, 2026, from 13F filings

Held by institutions
0.0%
0M of 1M shares
Institutional holders
0
0 new, 8 sold out
Net institutional buying
-0M
In Q1 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Foong Soon Hong, Randy10,588,2409.12%13G (passive)Jul 29, 2025
Tan Soo Seng10,392,1608.95%13G (passive)Jul 29, 2025
Tan Cheng Guan10,196,0808.79%13G (passive)Jul 29, 2025
Ching Choon Hwa9,803,9208.45%13G (passive)Jul 29, 2025
Orca Capital AG1,112,7889.90%13G (passive)Oct 8, 2026

Top institutional holders

13F holdings as of Dec 31, 2025

HolderShares% of SXTCValueChange% of portfolio
Citadel Advisors LLC130.00%$240.92K+90.00%
Invesco Ltd.70.00%$136.53K–0.00%
Geode Capital Management, LLC40.00%$85.87K–0.00%
XTX Topco Ltd20.00%$36.44KNew0.00%
Virtu Financial LLC10.00%$20.00K−10.00%
Tower Research Capital LLC (TRC)00.00%$2.92K–0.00%
Royal Bank of Canada00.00%$1.00KNew0.00%
UBS Group AG00.00%$356–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q1 202600M0.0%0 / 00 / 80M0M
Q4 202580M0.0%2 / 11 / 40M0M
Q3 2025100M0.0%7 / 11 / 10M0M
Q2 202540M0.0%2 / 10 / 00M0M
Q1 202520M0.0%2 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Feng Felix ZhouCo-CEO and Director40.00%Apr 27, 2026
Xiaodong Sean PanChief Financial Officer––Apr 27, 2026
Lim Sze Beng SimonCo-Chief Executive Officer––Apr 27, 2026
Jun ZhengDirector––Apr 27, 2026
Tong Tony LiuDirector––Apr 27, 2026
Yong Lip CheeDirector––Apr 27, 2026
Xiaodong JiDirector––Apr 27, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
2.95%
0M shares short
Days to cover
1.0
At 1M shares a day
Change since last report
-96.1%
From 1M shares
Short volume, 20 days
60.3%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of China SXT Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 17,243,334 shares on Oct 13, 2026 over the last 90 days.

See a number that looks wrong?